Introduction
In human as in veterinary medicine, antimicrobial agents are used therapeutically for the treatment of specific conditions of bacterial etiology. Concerning modern livestock industry, large amounts of antimicrobial agents are additionally used for prophylactic and metaphylactic purposes, as well as for growth promotion. Although antibiotic resistance genes occur naturally in many bacteria, overuse of antimicrobials and inappropriate antibiotic stewardship in both human and veterinary sectors have favored the emergence and dissemination of antimicrobial resistance (AMR) in bacteria. AMR has now become a public health problem of global dimensions. Major health organizations as well as governments acknowledge it as one the most significant threats not only to human health, but also to agriculture and economic growth [1] [2] [3] . In acknowledgement of this dire situation, an increasing number of governments have launched national and international strategies for tackling AMR, including USA, Canada, Great Britain, Germany, and Australia [4] [5] [6] [7] [8] . The declared aim is to improve antimicrobial stewardship, monitoring and surveillance, and international collaboration and, most recently in the case of the USA, reduce the use of antibiotics for growth promotion in food animals.
With regard to AMR, the US Centers for Disease Control and Prevention (CDC) prioritizes microorganisms into one of the three categories urgent, serious, and concerning [3] .
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Plasmids and Mobile Genetic Elements Play a Key Role in the Dissemination of bla ESBL Genes
Clones Are a Further Important Driving Force of the Spread of bla ESBL Genes
In clinical settings, CTX-M-15 has emerged as one of the most frequent ESBLs associated with a pandemic, highly virulent, multidrug-resistant E. coli defined by phylogenetic grouping [27] and multilocus sequence typing (MLST) [28] , as clone E. coli B2:ST131. This clone is considered to contribute greatly to the global dissemination of CTXM-15 and is associated with hospital as well as community-acquired infections [29, 30] . Other multidrug-resistant enterobacterial lineages of clinical importance include virulent extraintestinal clones belongThese and other clones and strains may harbor genes that code for virulence factors (VF) that are thought to increase adaptability, competitiveness, and ability to efficiently colonize the gastrointestinal tract and contribute to the successful dissemination of the clone [32] .
ESBLs Beyond the Clinical Setting
Colonization of the gastrointestinal tract is an important factor regarding the epidemiology of ESBL-producing Enterobacteriaceae. Recent years have seen a number of studies dedicated to scr eening for ESBL-producing Enterobacteriaceae in the fecal flora of humans in community settings, in animals, and in the environment. Fecal carriage of CTX-M-ESBLs in healthy humans is increasing significantly worldwide. A recent analysis of this trend detected vast differences between the world regions: In Europe, carriage rates range around or below 10 % whereas in parts of Southeast Asia and the Eastern Mediterranean, over 50 % of the population is currently found to harbor CTX-M-producing E. coli.
Plasmids can be defined as double-stranded circular DNA units that replicate autonomously within the bacterial cell and can be transferred via conjugation to bacteria of the same or of different species, promoting horizontal gene transfer [20] . Plasmids are categorized into families referred to as incompatibility (Inc) groups (or replicon types) and plasmid multilocus sequence types (pMLSTs), both of which can be determined using PCR methods [20, 21] . Different bla ESBLs are associated with particular plasmid replicon types. For example, bla CTX-M-15 is frequently identified on IncFII plasmids, which is a narrow host range plasmid group well adapted to proliferate in E. coli, whilst bla CTX-M-1 is predominantly found on plasmids belonging to broad host range IncI and IncN groups which are also found in isolates of animal origin [18, 22] . In addition, many resistance plasmids harbor toxin-antitoxin (TA) factors, which are so-called addiction systems that eliminate any post-segregational daughter cells that have not inherited the plasmid. This allows for vertical gene transfer and stable maintenance of plasmids within the bacterial population, even without selective pressure [23, 24] . Addiction systems have been demonstrated for IncF plasmids harboring bla CTX-M-15 [25] and for IncI plasmids harboring bla CTX-M-1 [26] . The presence of addiction systems in plasmids carrying bla ESBL genes and other resistance determinants contributes to epidemiological success of ESBL-producing bacteria.
ing to phylogenetic group D: E. coli D:ST38, E. coli D:ST405, and E. coli D:ST648 are all associated with CTX-M-9, CTX-M-14, and CTX-M-15 [31, 32] .
In most regions, CTX-M-15 is the most prevalent ESBL and is increasingly replacing CTX-M-14 in Asia, as well as CTX-M-2 in South America [33] . Other ESBL variants include CTX-M-1 and SHV-12 [34] . The increasing prevalence raises questions concerning the risk factors of gut colonization
ESBLs in Livestock Poultry
Zurfluh et al. [46] found that E. coli harboring bla CTX-M-1 on highly similar plasmids belonging to group IncI1 and pMLST 3 (IncI1/ST3 plasmids) are persistent at all levels in the Swiss broiler production farms, including day-old chicks. From this and other investigations in the Netherlands and Germany [47, 48] , it has become evident that the hatching eggs at the tip of the production pyramid play a central role as an entry point of ESBL-producing E. coli into broiler farms. In a longitudinal study, Laube and colleagues [48] demonstrated that ESBL-producing E. coli increase over time in broilers during the fattening period. It has been shown in all studies mentioned above that CTX-M-1-producing E. coli are maintained in broiler farms at detection levels between 50 and 100 %, even in the absence of antimicrobial selective pressure [49] . This high rate of contamination raises questions regarding the risks that occupationally involved humans and their environment are exposed to. An investigation of Dierikx and collaborators [50•] (Table 1) revealed that the prevalence of ESBL producers in Dutch broiler farmers was 33 %, which is In longitudinal studies investigating the transmission pathways of ESBL-producing E. coli from seven German broiler chicken farms and the farms' environs, Laube et al. [54•] (Table 1) analyzed samples taken from chicken feces, air and dust inside broiler barns and slurry, air, meadows, fields, grass, forest floors, and roads surrounding the broiler farms. It was thereby demonstrated that ESBL-producing E. coli can be transmitted via the ventilation system to a distance of at least 50 m from farms. Other emissions included the application of slurry from the broiler farms to fields. On Dutch broiler farms and on laying farms, Blaak and collaborators [55] (Table 1) found that soil, barn rinse water, flies, and fecal samples of farm resident pets tested positive for ESBL producers. With regard to ST, phylogenetic group, and ESBL genotype, 60 % of these isolates were identical to isolates from poultry feces at the same farms. Besides CTX-M-1, the ESBLs SHV-12 and TEM-52 were frequently observed (Table 1) . These findings are depicted schematically in Fig. 1 . Flies circulating throughout broiler farms, mainly Musca domestica, have been implicated as vectors of dissemination of ESBL producers [56] (Table 1) . Furthermore, in this study, Solà-Ginés and co-workers detected genes encoding VF, predominantly in E. coli A:ST10(CTX-M-1), including fimH, astA, iutA, iroN, iss, and traT, all of which are genes involved in avian disease as well as human extraintestinal infections, such as urinary tract infections [57] . The observations from the studies outlined above suggest a considerable risk of diffusion of ESBL-producing E. coli clones with possible zoonotic potential from broiler farms. among healthy people. Consumption of antimicrobials, hospitalization, premorbidity, African or Asian family background, and international travel have all been established as risk factors for an individual to become colonized with ESBL-producing bacteria [35] [36] [37] [38] [39] [40] . Moreover, there is growing concern that resistant E. coli originating from food animals may present a reservoir of ESBL-producing bacteria and an important threat to human health. Several studies have drawn attention to the possibility of the transmission of bla ESBL genes, their encoding plasmids, and the E. coli isolates via fresh food, in particular from poultry meat [41] [42] [43] [44] . From such studies, it has become evident that CTX-M-1 is currently one of the most prevalent ESBLs in food-producing animals, at least in poultry. Accordingly, CTX-M-1 constitutes the most frequently reported ESBL variant in the EU in E. coli originating from food-producing animals and foods [45] . It is becoming increasingly clear that livestock represents a major reservoir of ESBL-producing E. coli, although the actual impact of this reservoir on human health is still insufficiently understood, and linking antibiotic use in food-producing animals with resistance in human isolates is discussed controvers i a l l y. T h u s , u n d e r s t a n d i n g e p i d e m i o l o g y o f extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae in the human-livestock environment is important. Recent studies that provide further insight into this matter are listed in Table 1 and discussed below.
As stated above, poultry represents a major reservoir of CTX-M-1-producing E. coli. much higher compared to the 4.9 % described previously for the Dutch population [51] . In E. coli isolates from fecal samples from five of the six farmers, the combination of detected ESBL genes (bla CTX-M-1 and bla ) and the plasmid group on which the genes were located (IncI1 and IncN, respectively) corresponded to genes and plasmids found in isolates from cloacal samples from the broilers. Huijbers et al. [52•] (Table 1) [53] .
Pigs
Frequently observed ESBL variants in E. coli from fecal samples of healthy pigs include SHV-12, CTX-M-1-, CTX-M-9, CTX-M-14, and CTX-M-15 [58, 59] (Table 1) . Recently, pig farms have been identified as reservoirs for TEM-52 [60] ( Table 1) . TEM-52 was found associated to the most part with IncI1/ST3 plasmids and epidemic clone E. coli A:ST10. Additionally, CTX-M-1 and CTX-M-32 within IncN/ST1 plasmids and epidemic clone E. coli A:ST10 were detected in feces and on hides of pigs, in pig feed, and in liquid manure on pig farms located throughout Portugal [60] .
Fecal carriage of ESBL-producing Enterobacteriaceae in pigs is a dynamic process, as outlined in a longitudinal study by Hansen and collaborators [61] (Table 1 ). This Danish MLST multilocus sequence type, -not determined a Phylogroup: E. coli phylogenetic group b pMLST: plasmid MLST investigation analyzed the fecal flora of pigs bred in farrow-to-finish production systems. In such systems, the sows, piglets, weaners, and finishers are housed in separated sections on the same farm. On all farms, it was shown that fecal carriage of CTX-M producers was highest in the f a r r o w i n g a r e a a n d c o i n c i d e d w i t h t h e u s e o f extended-spectrum penicillins in sows and farrows. However, fecal carriage decreased significantly after weaning and was lowest in finishers just before slaughter, suggesting that certain practices during the process of production influence the status of fecal carriage. One such process was found to be thorough cleaning and disinfection of housing sections prior to moving batches of pigs. Thus, although the farrowing area may serve as a reservoir of ESBL producers, the contamination of following batches can be reduced by good sanitation.
Similar to broiler farms, emissions of ESBL producers from pig farms into the environment have been reported. An investigation conducted by von Salviati and colleagues [63•] (Table 1) on seven German pig fattening farms detected identical ESBL-E. coli isolates (with CTX-M-1 representing the majority) in pig feces, dust, barn air, flies, and mouse droppings and, further, in slurry and in digestate from biogas plants, both of which were intended for application on fields as fertilizers. In addition, fields fertilized 1 to 7 months before sampling tested positive for ESBL producers. Reviewing the results of this systematic study, the authors conclude that slurry from pig farms represents a significant emission source for ESBL producers. Furthermore, they suggest that biogas plants which apply mesophilic digestion, i.e., between 20 and 40°C, may need to improve treatment conditions to reduce the bacterial load in the digestate.
In pigs, respiratory infections are the main indication for using antimicrobials, followed by intestinal diseases in piglets, weaners, and fattening pigs and diseases of reproductive organs in sows [64] . In a study on the impact of ceftiofur treatment of pigs, Fleury et al. [65] observed a dramatic increase of shedding of CTX-M-1 E. coli for 3 days after injection.
Similar results were obtained by Vasseur and colleagues [66] , who showed that therapeutic doses of cefquinome resulted in a massive amplification of CTX-M-1-producing E. coli in the guts of laboratory rats.
Cattle and Sheep
ESBLs in cattle were first observed in fecal samples of cattle and cattle carcasses in Japan in 2000 [67] . The emergence of CTX-M-2 in cattle was attributed to the use of ceftiofur, which was the only expanded-spectrum cephalosporin approved for livestock in Japan at that time. Since then, CTX-M-1, CTX-M-13, and CTX-M-14 have been detected sporadically in E. coli from cattle in Europe and Asia [10] . In 2010, CTX-M-1-producing E. coli was reported for the first time in cattle in the USA [68] . Currently, in Europe, the prevalence of ESBL producers in fecal swabs of healthy cattle is 5-13 %, with CTX-M-1 the most prevalent variant [69, 70] . Since third-generation cephalosporins, namely ceftiofur and cefquinome, are frequently used to treat diseases such as pulmonary infections and mastitis in cattle, the question is controversially discussed of whether the therapeutic use of cephalosporins as well as the subtherapeutic use of other antimicrobials (i.e., growth promoters/digestive enhancers) has contributed to the emergence of ESBLs in cattle and other livestock. Schmid et al. [71] found that on German mixed dairy cattle/beef farms, ESBL-producing E. coli strains (mainly CTX-M-1 producers) were significantly more often detected Hammerum and co-workers [62•] (Table 1) showed that farm workers with direct contact to ESBL-positive pigs had a fecal carriage rate of ESBL producers of 21 %. On four of 20 farms, the combination of ESBL genes (mainly CTX-M-1 encoded on IncI1, IncF, or IncN plasmids) and ESBL-producing E. coli clones, notably E. coli A:ST10 (CTX-M-1) and A:ST10(CTX-M-14), was shared with fecal isolates from the pigs on the same farm (Fig. 1) . This strongly suggests transmission between pigs and humans. Interestingly, transfer of ESBL-producing E. coli from farmers working with pigs to family members not working with pigs was not detected.
in fecal samples from calves treated with antimicrobials (β-lactams as well as others) than in untreated calves. They further stated that calves being fed waste milk (which may contain antibiotic residues) harbored more ESBL-producing E. coli. Milk from cows with mastitis may contain CTX-M-1-and CTX-M-14-producing Enterobacteriaceae, albeit at a very low rate of 0.4 %, as demonstrated in an extensive screening study conducted in France by Dahmen and co-workers [72] .
Cottell and co-workers [73] (Table 1) observed the emergence of CTX-M-32-producing E. coli in the fecal samples of 29 of 88 (33 %) steers receiving either ceftiofur (14 animals), chlortetracycline (4 animals), or both treatments (11 animals).
A longitudinal study conducted by Hordijk and collaborators [74] (Table 1) showed that veal calves collected from different EU countries to be distributed on Dutch fattening farms brought with them a high diversity of fecal ESBL producers, with CTX-M-1, CTX-M-15, CTX-M-32, and TEM-52 detected most frequently. On all three fattening farms under observation, ESBL diversity declined after prophylactic antimicrobial group treatment and was replaced over a time period of 6 weeks with farm-specific clones: E. coli ST57 harboring bla CTX-M-14 on an IncF F2:A-:B-plasmid on one farm and E. coli ST10 harboring CTX-M-14 on an IncK plasmid on another. The o b s e r v a t i o n s f r o m t h i s s t u d y s u g g e s t t h a t decontaminating pens and other housing facilities prior to arrival of veal calves for fattening could help control (re)colonization of calves and the clonal spread of ESBL producers in veal calves before slaughter.
Currently, there is a paucity of data available on the fecal carriage rate and risk factors for individuals who have frequent contact with cattle. However, based on the studies on fecal carriage of poultry and pig farmers discussed above, it is reasonable to assume that a similar occupational hazard exists for cattle farmers. Moreover, pasture soil, manure from cattle, and amended fields testing positive for ESBL-producing E. coli provide evidence for cattle farms as emission sources of ESBL producers [69] (Table 1, Fig. 1) .
Reports on ESBL producers in fecal samples of sheep are rare but show that, to date, CTX-M-14 predominates, at least in Switzerland [70] and the UK [75] . However, a recent study conducted by Ramos and collaborators [76] (Table 1) showed that CTX-M-32 is predominant in the feces of healthy sheep at slaughter in Portugal. Furthermore, this study revealed that ESBL producers isolated from cattle and sheep may contain genes encoding VF such as aer and fimA, which are associated with extraintestinal pathogenic E. coli.
Together with other studies that analyze ESBL-producing E. coli in pigs and pork [59] and poultry and poultry meat [41] , these results demonstrate that livestock may represent a reservoir of virulence genes as well as bla ESBLs .
Pathogenic ESBL Producers in Livestock
Although livestock represents a major source of ESBL-producing commensal E. coli, it is unclear to what extent bla ESBL genes are transferred to zoonotic pathogens. For example, only few ESBL-producing enterohemorrhagic E. coli (EHEC) strains have been reported [77] . This is surprising, since cattle are recognized as the main reservoir of EHEC. Nevertheless, CTX-M-1 is detected increasingly in other zoonotic pathogens, mostly Salmonella spp., for instance, in S. Anantum and S. Infantis from cattle and S. Paratyphi B from chicken in Germany [78] , in S. Llandoff from chicken in France [79] , in Salmonella spp. from turkeys and from a pig in USA [80] , and in Salmonella 4,5,12:i:2-as well as in S. Bovismorbificans from pigs in the UK [81] . In all these cases, bla CTX-M-1 was frequently harbored on IncI1 or IncN plasmids, which is suggestive of horizontal genetic transfer from commensal E. coli to Salmonella within the animal gut. Although currently rare, the prevalence of pathogenic CTX-M-1 producers of animal origin involved in human infections must therefore be expected to increase in future.
Conclusions
ESBL producers are frequent in the fecal flora of healthy livestock. Certain ESBLs (predominantly CTX-M-1, but also CTX-M-14 and CTX-M-32) are characteristics to livestock, and their occurrence is frequently linked to specific plasmids (IncI1, IncN) and E. coli clones (e.g., A:ST10, A:ST23). Data from recent studies suggest that the therapeutic use of expanded-spectrum β-lactams, in particular ceftiofur in cattle and pigs, promotes the emergence and dissemination of CTX-M-1-and CTX-M-32-producing E. coli within farms. The studies highlighted in this review provide evidence for the transmission of ESBL-producing commensal E. coli from livestock to humans occupationally involved in farming and to the environment of livestock farms, including air, pathways, slurry, fertilized fields, and digestate from biogas plants. The impact of ESBL producers of animal origin on human health and environmental integrity is just beginning to become apparent. The implementation of international and national mitigation strategies including increased surveillance and monitoring of AMR as well as the optimization of therapeutic strategies for livestock is necessary. On regional and local scales, it is urgent to provide solution-focused approaches. These could include improvements in biosecurity and hygiene practices on farms to reduce the occupational risk for farmers and new approaches targeting the safer disposal of gastrointestinal waste material (slurry, manure, biogas digestate) in order to limit the transmission of ESBL-producing E. coli into the environment.
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